Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Generous Dividend Payout and Solid Reputation United Securitys Commitment to Shareholders

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Finance_Fiscal (2)
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On January 19, 2024, United Security (NASDAQ:UBFO) will generously reward its valued shareholders by distributing a dividend payout of $0.12 per share. This remarkable dividend offering translates to an impressive annualized dividend yield of 5.59%. However, it is important to note that only investors who held the stock prior to the ex-dividend date on January 02, 2024, will be eligible to receive this lucrative payout.

When evaluating United Security’s dividend yield in comparison to its industry peers, the company finds itself in a favorable position, comfortably situated in the middle. It is worth mentioning that Penns Woods Bancorp (NASDAQ:PWOD) currently boasts the highest annualized dividend yield among its peers, standing at an impressive 6.14%.

Various sources report a slightly varying range for United Security Bancshares’ 12-month trailing dividend yield, estimated to be around 5.54% to 6.29%. This demonstrates the company’s commitment to consistently rewarding its shareholders, further solidifying its reputation as a reliable and financially sound investment option.

PWOD Stock Analysis: Potential Buying Opportunity Despite Bearish Sentiment

On January 19, 2024, PWOD stock experienced a flat performance with no significant price change. The stock is currently trading near the bottom of its 52-week range, suggesting a potential buying opportunity for investors. However, it is worth noting that PWOD is trading below its 200-day moving average, indicating a bearish sentiment and the possibility of further downside in the future. The lack of movement in the stock’s price on this particular day could be attributed to a lack of significant news or events. Investors should exercise caution, conduct thorough research, and stay updated with the latest market developments before making any investment decisions.

PWOD Stock Performance on January 19, 2024: Analyzing Revenue, Net Income, and EPS

PWOD Stock Performance on January 19, 2024: A Closer Look at the Numbers

Total Revenue:

PWOD’s total revenue for the past year stood at $73.64 million. Comparing this figure to the previous year, we observe a 5.08% increase, indicating a positive growth trajectory. Moreover, the company experienced a 7.87% increase in total revenue since the last quarter, reflecting continued momentum in their business operations.

Net Income:

The net income of PWOD for the past year amounted to $17.42 million. This represents an 8.66% increase when compared to the previous year. However, the net income for the last quarter was $2.22 million, reflecting a decrease of 46.68% compared to the previous quarter. It is important to note that while the yearly net income shows positive growth, the quarterly net income has experienced a decline, which may raise some concerns among investors.

Earnings Per Share (EPS):

PWOD’s earnings per share for the past year were $2.47. This figure reflects an 8.7% increase compared to the previous year. However, the earnings per share for the last quarter were $0.31, indicating a significant decrease of 47.92% since the previous quarter. Similar to the net income, the quarterly EPS has experienced a decline, which might be a matter of concern for investors.

Analyzing the data provided, PWOD’s total revenue has shown consistent growth both annually and quarterly, indicating a positive trend. However, the net income and EPS figures are more volatile, with a significant decrease in the last quarter. This volatility might be attributed to various factors such as market conditions, operational challenges, or one-time events.

Investors should carefully assess the reasons behind the decline in net income and EPS for the last quarter to determine whether it is a temporary setback or a more significant issue. Additionally, it is crucial to consider PWOD’s financial health, industry trends, and future growth prospects before making any investment decisions.

It is important to note that the stock market is influenced by multiple factors, and past performance may not necessarily guarantee future results. Investors should conduct thorough research and consult with financial professionals before making any investment decisions.

Tags: PWOD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Banking Markets and money

Metropolitan Bank Holding Corp Reports Mixed Q4 Financial Results

Finance_ blue chart

Impressive Financial Performance and Exceeding Expectations World Acceptance Corporations Third Quarter Fiscal 2024 Results

Automotive Stock Market Today

Hertz Global Holdings Faces Downgrade but Analysts Remain Optimistic

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com